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The  "original  antigenic  sin"  phenomenon  (OAS) 1 challenges  the dogma of the 
specificity of the immunological memory: when there is sequential infection with 
two different but antigenically related strains  of influenza A virus, the antibody 
stimulated  by the second infection reacts more strongly with the primary virus 
than with the one actually eliciting the response (1-3). This phenomenon is now 
well  documented  with  many  viral  and  nonviral  cross-reacting  antigens  (4-8). 
However, its study with influenza  antigens  is of special interest  because of its 
wide implications in the sero-epidemiology of influenza and the response to vac- 
cination. In the accompanying paper (9) we have shown that purified hemaggluti- 
nin (HA) extracted from related influenza viruses share cross-reacting antigenic 
determinants,  but differ in strain-specific  determinants.  We have now analyzed 
the antibody  response to each of these  groups  of determinants  after sequential 
exposure of mice to two related HA's, and have carried out cell-transfer experi- 
ments  in  an  attempt  to  elucidate  the  cellular  mechanisms  responsible  for the 
aberrant immunological recall of the OAS phenomenon. 
Materials and Methods 
Animals,  Immunization  Schedules,  Preparation  of Purified-Concentrated  Viruses, Bromelain- 
Extraction  of  HA.  The  animals,  immunizations,  etc.,  and  the  independent  measurement  of 
* Visting  scientist  supported  by  a  fellowship  from  the  Delegation  Generale  a  la  Recherche 
Scientifique et Technique, Paris. 
~Abbreviations used in this paper: CR,  cross-reacting population of antibody; H,, cross-reacting; 
Ha, unrelated hemagglutinin; HA, purified hemagglutinin; Ho, homologous; OAS, original antigenic 
sin;  Sl,  strain-specific  antibodies  to  H~  hemagglutinin;  So,  strain-specific  antibodies  to  Ho 
hemagglutinin; SRDT,  single radial diffusion tests; T ÷ mice, immunologically intact mice; TXBM 
mice, thymectomized, irradiated, and bone marrow reconstituted mice. 
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antibody to  strain-specific and  cross-reacting determinants of the  HA  molecule by  single-radial 
immunodiffusion have been described in the accompanying paper (9). 
Preparation of Spleen Cell Suspensions.  Single-cell suspensions were obtained by gentle forcing 
through a stainless steel sieve; they were then washed, and resuspended in L 15 medium. 
Anti-O Serum.  AKR anti-~ C3H serum and fresh rabbit serum were separately absorbed twice 
with an equal volume of a fresh liver suspension collected from normal CBA mice, for 1 h at room 
temperature. A mixture of 1 vol of packed spleen cells, 1 vol of undiluted fresh rabbit serum and 2 vol 
of anti-O  serum diluted  1:10 (final dilution 1:20) was incubated at 37°C for 1 h  with intermittent 
gentle mixing, washed twice, and resuspended in L 15 medium. The viability of these treated spleen 
cell suspensions was about 60%-65%  before transfer. 
Results 
Responses  of  Ho-Primed  Mice  to  Homologous  or  Heterologous  Boosting. 
Groups of mice were  primed with three  injections of 10  ttg  Ho hemagglutinin 
(bromelain-extracted from  influenza A/PR8 virus)  and  left for 2  mo  without 
further  immunization.  The  animals  were  then  boosted  with  10  tLg  of either 
homologous  (Ho),  cross-reacting  (Hi),  or  unrelated  (H3) hemagglutinin. The 
arithmetic mean of antibody titers for each group  was  calculated in  the  sera 
collected 7, 14, and 21 days after the boost and tested for potency and specificity 
in single-radial-diffusion immunoplates (SRDT). Unprimed animals did not give 
any  detectable  response,  10  #g of either  Ho  or  Hi  being below the  threshold 
immunogenic dose  of these  antigens.  Fig.  1 shows that the  H3  boost did  not 
modify the progressive antibody decrease observed 2 mo after priming. The Ho 
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Fl(;.  1.  Secondary  response  curves  of  antibodies  to  different  antigenic  determinants  of 
bromelain-extracted HA molecule in Ho-primed mice boosted with 10 #g of either H~ (Ho/H3 
sequence), Ho  (Ho/Ho sequence), or  H1  (Ho/H~  sequence). Changes in  antibody titers are 
expressed as differences (in mm  2 of zone areas) between arithmetic mean of titers for groups of 
10 mice before the boost and 7, 14, and 21 days after the boost. The specificity and potency of 
each  antibody  population  were  determined by  cross-absorption in  single-radial  diffusion 
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antigenic determinants present in the Ho molecule (So, strain-specific and CR, 
cross-reacting) as expected. Paradoxically, the H1 boost was also followed by a 
secondary-type antibody response  of the  So  specificity, and  thus  specific  for 
antigenic determinants which are not present in the boosting antigen. A third 
antibody population was found in the latter group (Ho/HI sequence), which was 
not absorbable by A/PR8 virus in SRDT containing A/FM1 virus (S~ population, 
strain-specific for  H~). The  kinetics  of the  response  of the  $1  population ap- 
peared to be  intermediate between these typical of a  primary and a  secondary 
humoral response, since 10 vg of H~ is not an immunogenic dose in virgin ani- 
mals. 
Transfer  of Ho-Primed  Memory  Cells.  Spleen  cells  from  Ho-primed  mice 
were transferred into irradiated recipients either as a whole population (after in 
vitro treatment with an non-T-cell cytotoxic normal mouse serum and comple- 
ment), or as a T-cell-depleted population (after treatment with anti-0 serum and 
complement). Table I shows that the recipient animals injected with either Ho or 
H1 had a secondary response of both the So and the CR specificity, even when the 
spleen  cells  were  transferred  after  anti-0  serum  treatment.  The  amount  of 
antibody secreted was the same whether or not primed T  cells were transferred 
together with the primed B cells, except in the case of the recipients boosted with 
Ho  which  produced  almost  three  times  more  So  antibodies  after  transfer  of 
untreated spleen cells. 
Table II shows the results of an experiment involving transfer of anti-0 treated 
Ho-primed  spleen  cells  into either normal  (T +)  or  thymus-deprived (TXBM) 
recipient  mice.  Again,  a  successful  adoptive  transfer  of So-specific  and  CR- 
specific memory cells was found, even following transfer of spleen cells collected 6 
TABLE I 
Antibody Responses of Irradiated Mice After Transfer of HO-Primed Spleen Cells Either 
Treated or Not with Anti-O Serum and C 
Irradiation  Treatment  Compar-  Com- 
of recipient  Spleen cells  of cells in  Boosting  Anti-SO  ison  Anti-CR  parison 
mice*  transferred~  vitro§  antigen[[  response¶  between  response¶  between 
groups  groups 
x 600 R  Virgin  0  HO  0  --  0 
x 600 R  0  0  HO  0  --  0 
×600R  HO-primed  Anti-0 serum  HO  9.2  ~  2.5  1 
+  C  (7.0-12.0)  (0.6-4.4) 
x600R  HO-primed  NMS + C  HO  25.1  ~  x2.9  2.0  I 
(15.O-42.0){  (2.0-2.0) 
x600R  HO-primed  Anti-0serum  H~  4.0  ' 
.0401  +  C  (7.  8)  ~1  3.9 
x600 R  HO-primed  NMS + C  H~  (5.4-10.7) ~  (2.0-5.4) I 
m 
* Mice were submitted to a 600 rads total body irradiation ( x600 R) 4 h  before cell transfer. 
1.2 x  108 syngeneic spleen cells from a pool of unprimed animals or a pool of animals primed by three injections of 
10 ug 2 mo previously were injected i.p. per recipient mouse. 
§ Cells were treated by either AKR anti-0 C3H serum (final dilution 1:20) and C or normal CBA mice serum (NMS) 
and C. 
[[ Recipients were injected i.p. with 10 ~g of either HO or H~ 24 h  after cell transfer. 
¶ Sera collected individually 14 days after boosting injections were tested and analyzed for specificity in SRDT 
plates as described in Methods. Range is indicated between parentheses. 1574  ANTIBODY RESPONSES TO INFLUENZA HEMAGGLUTININ. II 
TABLE II 
Antibody Responses of T + or TXBM Mice After Transfer of HO-Priraed Spleen Cells 
Treated In  Vitro with Anti-# Serum and Complement 
Anti-6 
serum in 
Recipient  Spleen cells  vitro  Boosting 
mice  transferred*  antigen §  treat  - 
ment$ 
Determinants specific antibody 
levels in SRDT (in mm2)[I 
SO population  CR population 
T ÷  Virgin  0  HO  0  0 
T ÷  HO-primed  +  0  0  0 
T +  HO-primed  +  SRBC  0  0 
T ÷  HO-primed  +  Hs  0  0 
T ÷  HO-primed 6 mo  +  HO  2.9 (2.8-3.5) ¶  0 
previously 
T +  HO-primed  +  HO  6.8 (5.4-7.6)  2.5 (1.8-3.0) 
TXBM  HO-primed  +  HO  8.0 (5.4-10.0)  2.7 (2.7-2.8) 
T +  HO-primed  +  Hx  4.0 (3.9-4.4)  2.0 (1.1-2.6) 
TXBM  HO-primed  +  HI  6.0 (4.4-7.0)  3.2 (2.6-3.9) 
* 1.0 x  108 spleen cells from a pool of animals primed by three injections of 10 ttg HO were injected 
per recipient mouse. Cells were collected 2 mo after priming, unless stated otherwise. 
Groups marked +  received cells previously treated in vitro with AKR anti-0 C3H  serum {final 
dilution 1:20) and complement. 
§ 24 h after cell transfer mice were injected i.p. with either 10 ttg of H3, HO, or H~, or 10 x 106 SRBC. 
II Sera collected individually 7 days after boosting injection were tested and analyzed for specificity  in 
SRDT plates, as described in Methods. 
¶ Range of responses is indicated between parentheses. 
mo  after  priming.  Both  Ho  and  H~,  but  not  Hs  were  able  to  recall  this 
immunological  memory.  Paradoxically,  the  So antibody  response  was  found  in 
repeated  experiments  to be slightly higher in TXBM  than  in T ÷ recipients. 
Discussion 
The  experiments  reported  in  this  paper  show  that  the  original  antigenic  sin 
phenomenon  is  demonstrable  at  the  level  of  the  purified  influenza  virus 
hemagglutinin  antigens,  since  Ho-primed  mice  boosted with the  cross-reacting 
H1  showed  a  secondary anti-Ho response.  Our results underline the necessity of 
antigenic  relationship  between  the  priming  and  the  boosting  antigen  in  the 
phenomenon,  since the  unrelated  Ha was  not  able to recall this immunological 
memory.  It is hazardous  to compare  our results obtained  in mice using purified 
viral  antigens  to  the  human  epidemiological  findings.  However,  data  very 
similar to ours have been obtained  in persons previously immune  to Ho-bearing 
viruses (e.g. A/PR8/34)  or Hi-bearing viruses (e.g. A/FM1/47), who did not show 
any  anti-A/PR8  or  anti-A/FM1  antibody  recall  when  they  were  infected  with 
A/Hong-Kong/1/68 virus bearing H3 hemagglutinin  (10,  11). 
H1  hemagglutinin,  when  boosting  Ho-primed  animals,  elicits  a  secondary 
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the  strain-specific  determinant  of a  first  hemagglutinin  (Ho)  are  produced  in 
response  to  a  second  hemagglutinin  (H~)  which  does  not  contain  the  same 
strain-specific determinant. This observation conflicts with the report of Fazekas 
de Saint-Groth and Webster (2,  3)  that every antibody produced after a  sequen- 
tial immunization with cross-reacting strains of influenza A virus was cross-reac- 
tive and capable of being absorbed by both strains of virus. However, results very 
similar  to ours  have been  found with  different  cross-reactive antigens,  such as 
serum  albumins  (4),  HL-A  antigens  (5),  cross-reacting  haptens  (6,  7),  and 
streptococcal antigens (8).  This "aberrant" antibody recall directed against the 
specific determinants of the first of two related sequential antigens appears to be 
a  characteristic of the OAS phenomenon. 
At  the  level  of the  memory  cells,  such  a  paradoxical  phenomenon  has  two  possible 
explanations.  Either  T-memory  lymphocytes,  with  a  broader  specificity  than  the  B 
lymphocytes,  are  triggered  by  the  cross-reacting  antigen  and  are  then  able  to  help 
B-memory lymphocytes to secrete antibody specific for the first antigen, as suggested in 
other systems (12-14),  or B-memory cells with specificity for the first antigen are directly 
triggered by  the  cross-reacting antigen.  Our  results  favor the  latter  hypothesis,  since 
Ho-primed spleen  cells  transferred  after treatment  with  anti-0 serum and complement 
were able to secrete So antibody in either irradiated or thymus-deprived recipients after a 
boost with H~. 
It is conveivable that a small number of residual T cells might have escaped the effect of 
anti-0 serum and might have exerted a helper effect in the second host. However, in the 
case of the Ho-H~ sequence, no significant difference in antibody titers was observed in 
irradiated  recipients,  whether the transferred primed cells  had been treated with anti-0 
serum or not (see Table I). This result cannot be attributed to an incomplete activity of 
antiserum,  since  the  same  in  vitro  treatment  greatly reduced the  secondary antibody 
response of the same cell preparation in the case of an Ho/Ho sequence. Thus, B-memory 
lymphocytes appear to be directly responsible for the OAS phenomenon. 
Our finding that H~ can trigger 8o memory B lymphocytes is puzzling, since it implies 
some "error" in antigen recognition by B cells. Receptors for antigen on the surfaces of B 
lymphocytes are generally believed to be antibody molecules (15).  However, findings of 
Pernis (16) indicate that membrane-fluorescing antibody in some B cells is not of the same 
class  as  cytoplasmic  fluorescing  antibody,  suggesting  a  possible  distinction  between 
receptor  antibody and  secreted  antibody.  The  two might not  have  precisely the  same 
specificity.  Our  results  lead  to  the  conclusion  that  receptors  for  antigen  on  some  B 
lymphocytes may have broader specificity than the antibody molecules finally secreted by 
the cells. This interpretation is in agreement with the work by Klinman et al. (17) showing 
that primed B cells  are less fastidious in their affinity requirements for stimulation than 
precursor B cells, and are not rigorously determinant specific.  In our system, it is possible 
that repeated priming with the strain-specific determinant of Ho leads to the development 
of subpopulations  of B  cells  with  receptors  of broader  specificity  able  to  recognize a 
different but probably structurally similar determinant within the H~ molecule. 
Cooperation between T- and B-memory cells has been shown to occur during the 
secondary humoral response of mice to foreign erythrocytes (18) as well as in the 
hapten-carrier system  (19).  We present evidence that such co-operation occurs 
during the anti-HA response: Ho-primed B cells boosted with Ho in a secondary 1576  ANTIBODY RESPONSES  TO  INFLUENZA HEMAGGLUTININ.  II 
host secreted three times more anti-So antibody when transferred together with 
Ho-primed T  cells than when transferred after anti-0 treatment. However, CR 
antibody  titers  were  not  influenced  by  the  presence  of  Ho-primed  T  cells, 
indicating that T-memory cells had specificity for the strain-specific determi- 
nants of the priming hemagglutinin and had provided their helper effect only to 
So-secreting  B-memory cells.  Similarly, we  have  shown in the  accompanying 
paper that help by virgin T cells is required for the So response but not for the CR 
response.  This  correlation suggests a  quantitative change between virgin and 
memory T cells, the quality of the co-operation provided to B cells remaining the 
same. Moreover, animals primed with Ho produced an unusually high titer of 
primary $1 antibody when boosted with H1 antigen. Thus, Ho-primed lympho- 
cytes appear to help virgin B cells to produce antibody against the new antigenic 
determinant  eliciting  the  primary  $1  response.  This  is  likely  to  be  due  to 
T-memory cells, since anti-Ho B-memory cells should be committed to secrete 
only anti-So and anti-Cr antibodies. The same interpretation has been drawn by 
Cunningham and  Sercarz  (20) for similar results obtained with cross-reacting 
erythrocytes. 
Evidence  is  given  in  the  present  study  that  T  cells  can  cooperate  with 
B-memory cells in either a positive or a negative way, depending on experimental 
conditions. While T  cells were shown in the accompanying paper to provide a 
positive helper effect during the  primary anti-Ho antibody response,  the data 
now reported  show that T  cells present  in normal recipients were not able  to 
enhance,  and  indeed seemed to  suppress  partially, the  secondary response  of 
transferred B-memory cells. Preliminary results in our laboratory indicate that 
IgG  antibodies  were  secreted  in  the  former  case  while  IgM  antibodies  were 
secreted in the latter (Virelizier and Allison, manuscript in preparation). This 
suggests  that  different  kinds  of B  cells  were  reacting  in  these  two  different 
situations,  and that only IgM-producing cells can secrete antibody independ- 
ently of T  cells. This is discussed further in relation to the nature of the selection 
involved in the kinetics of the immune responses to influenza HA and the OAS 
phenomenon. 
Summary 
Mice  immunized sequentially with two related influenza virus hemagglutinins 
(HA)  produced a  secondary antibody response with two different specificities. 
Some antibodies were specific for determinants common to both HA's. Paradoxi- 
cally, some antibodies were directed to determinants existing only in the HA first 
encountered.  Primed  spleen  cells  treated  with  anti-0  serum  and  complement 
were transferred from animals immunized with the first HA to either normal, 
irradiated,  or thymus-deprived recipients. These memory cells were boosted in 
the recipients with either the homologous or the heterologous cross-reacting HA. 
B-memory lymphocytes were shown to be directly triggered by both HA's and to 
be able to secrete, independently of T  lymphocytes, antibodies to both kinds of 
determinants. However, T cells were shown to modulate this secondary response 
by  either  enhancing  or  suppressing  antibody  secretion  by  B-memory  cells, 
depending on experimental conditions. These results are discussed in terms of J.-L.  VIRELIZIER, A.  C.  ALLISON,  AND G.  C.  SCHILD  1577 
antigen recognition by B  cells and of kinetics of development of immunological 
memory. 
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